Revathi Advaithi - Jul 31, 2023 Form 4 Insider Report for FLEX LTD. (FLEX)

Signature
/s/ Revathi Advaithi, by Kristine Murphy as attorney-in-fact
Stock symbol
FLEX
Transactions as of
Jul 31, 2023
Transactions value $
-$6,549,264
Form type
4
Date filed
8/2/2023, 09:01 PM
Previous filing
Jun 16, 2023
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLEX Ordinary Shares Sale -$6.55M -240K -13.15% $27.29 1.59M Jul 31, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Price reflects weighted average sales price; actual sales prices ranged from $27.10 to $27.57. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F2 Includes the following: (1) 197,824 unvested restricted share units ("RSUs"), which will vest in two equal annual installments beginning on June 1, 2024; (2) 86,901 unvested RSUs, which will vest on June 9, 2024; and (3) 197,072 unvested RSUs, which will vest in three equal annual installments beginning on June 14, 2024.
F3 Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited.

Remarks:

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.